Resistance rates of non-albicans Candida infections in Taiwan after the revision of 2012 Clinical and Laboratory Standards Institute breakpoints

by Hii IM, Liu CE, Lee YL, Liu WL, Wu PF, Hsieh MH, Ho MW, Chen YH, Wang FD
Published 2019-01-01

In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 201...

by Jean SS, Lu MC, Shi ZY, Tseng SH, Wu TS, Lu PL, Shao PL, Ko WC, Wang FD, Hsueh PR
Published 2018-10-01